期刊文献+

脊柱手术围手术期抗菌药物预防应用干预效果评价 被引量:9

An Evaluation of Intervention Effect to Antibiotic Prophylaxis During Perioperative Period of Spinal Surgery
下载PDF
导出
摘要 目的探讨围手术期抗菌药物预防用药合理性及抗菌药物临床应用专项整治活动的干预效果。方法选取北京市某三级医院脊柱I类切口手术病例整治前2011年1—3月673例及整治后2014年1—3月974例进行对比分析,比较抗菌药物预防应用情况。结果整治后,抗菌药物的首次用药时机、用药疗程、品种选择、给药途径、联合用药的合理率分别由整治前的6.61%、2.67%、7.73%、10.25%、8.62%提升至50.93%、49.79%、91.58%、94.35%、91.38%,差异均有统计学意义(P<0.05)。结论整治活动对于规范脊柱I类切口手术围手术期抗菌药物预防应用很有成效,明显提高用药合理性。 Objective To explore the changes of using antimicrobial drugs during surgical perioperative period after the promulgation of The Modified Clinical Application of Antibacterial Drugs Action Plan and analyze the intervention effect.Methods We identified 974 medical records of patient who received spinal surgery whereas type I incision from January to march,2014 and compared it with 974 medical records of patient who received spinal surgery whereas type I incision from January to march,2011 from the same tertiary hospital in Beijing. Results After the promulgation of The Modified Clinical Application of Antibacterial Drugs Action Plan,the timing accuracy increased from 6.61% to 50.93%.The duration become shorter. The selection accuracy increased from 7.7% to 91.4%. The route of administration accuracy increased from 10.3% to 94.2%. The combination accuracy increased from 8.6% to 90.8%. Conclusion After the promulgation of The Modified Clinical Application of Antibacterial Drugs Action Plan,practices of antimicrobial drugs use in spinal surgery whereas type I incision during surgical perioperative period has a obviously positive change.
出处 《中国医院管理》 北大核心 2016年第4期49-51,共3页 Chinese Hospital Management
关键词 抗菌药物 Ⅰ类切口 预防用药 spine antibacterials prophylaxis
  • 相关文献

参考文献9

二级参考文献30

  • 1张志清.国内抗菌药物应用现状及实施抗菌药物合理应用干预的可行性与难点[J].中国药房,2004,15(12):708-710. 被引量:111
  • 2陈晋,蔡德芳,何琴,王丽,刘建平,张松.围手术期预防性使用抗菌药物调查与分析[J].昆明医学院学报,2012,33(3):76-80. 被引量:3
  • 3陈解语.PDCA循环在合理使用抗菌药物管理中的应用[J].中华医院感染学杂志,2007,17(1):75-77. 被引量:57
  • 4卫生部办公厅.卫生部办公厅关于抗菌药物临床应用管理有关问题的通知[Z].2009.
  • 5卫生部.关于做好全国抗菌药物临床应用专项整治活动的通知(卫办医政发[2011]56号)[z].北京:卫生部,2011.
  • 6Ison C A. Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment[J]. Curt Opin Infect Dis, 2012, 25(1): 73-78.
  • 7刘庭芳,刘勇.中国医院评审评价追踪方法学操作手册[M].北京:人民卫生出版社,2012.
  • 8卫生部.医疗机构药事管理暂行规定(卫医政发[2002]24号)[Z].2002.
  • 9Xiao Y, Li L. Legislation of clinical antibiotic use in China[J]. Lancet Infect Dis, 2013, 13(3): 189-191.
  • 10Yang L, Liu C, Ferrier J A, et d. The impact of the Natimud Essen- tial Medicines Policy on prescribing behaviours in primary care facili- ties in Hubei province of China[J]. Health Policy and Planning 2015, 28: 750-760.

共引文献187

同被引文献86

引证文献9

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部